NihBiotechGrantPulse / compare

REVBIO, INC. vs MCM6 THERAPEUTICS, INC.: NihBiotechGrantPulse comparison

MCM6 THERAPEUTICS, INC.'s award of $1,284,978 is 1.0x REVBIO, INC.'s $1,276,407 (91st percentile). REVBIO, INC. is dated 2026-09-23; MCM6 THERAPEUTICS, INC. 2026-09-17.

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

Both records plus every comparable MA record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does REVBIO, INC. compare to MCM6 THERAPEUTICS, INC.?

FieldREVBIO, INC.MCM6 THERAPEUTICS, INC.
OrganizationREVBIO, INC.MCM6 THERAPEUTICS, INC.
LocationLowell, MALEXINGTON, MA
ProjectUse of an Innovative Pre-Formed Structural Scaffold for Reconstruction of Segmental Bone Loss in a Zygomaticomaxillary Complex ModelTargeting Brain Lipid Dysregulation in APOE4 Alzheimer's Disease with ACC Antisense Oligonucleotides
Project number1R44DE035431-012R42AG087802-02
MechanismR44R42
InstituteNational Institute of Dental and Craniofacial ResearchNational Institute on Aging
Award$1,276,407$1,284,978
Awarded2026-09-232026-09-17
Project period2026-09-23 to 2028-08-312024-09-25 to 2028-05-31
UEIZBTLVWJKASA8C2QTGJ6PU7S6
award percentile91st91st
Lab Budget Score70/10070/100
Peer rank and all 500 MA records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: REVBIO, INC. · MCM6 THERAPEUTICS, INC.

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together